Cyclic diguanylate signaling in Gram-positive bacteria

被引:55
作者
Purcell, Erin B. [1 ]
Tamayo, Rita [1 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, 125 Mason Farm Rd,CB 7290, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
cyclic diguanylate; motility; biofilm; adherence; signaling; Gram-positive; C-DI-GMP; REGULATES BIOFILM FORMATION; FIBRONECTIN-BINDING PROTEIN; CLOSTRIDIUM-DIFFICILE; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; IV PILI; GENE-EXPRESSION; TWITCHING MOTILITY; STREPTOMYCES-COELICOLOR;
D O I
10.1093/femsre/fuw013
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The nucleotide second messenger 3'-5' cyclic diguanylate monophosphate (c-di-GMP) is a central regulator of the transition between motile and non-motile lifestyles in bacteria, favoring sessility. Most research investigating the functions of c-di-GMP has focused on Gram-negative species, especially pathogens. Recent work in Gram-positive species has revealed that c-di-GMP plays similar roles in Gram-positives, though the precise targets and mechanisms of regulation may differ. The majority of bacterial life exists in a surface-associated state, with motility allowing bacteria to disseminate and colonize new environments. c-di-GMP signaling regulates flagellum biosynthesis and production of adherence factors and appears to be a primary mechanism by which bacteria sense and respond to surfaces. Ultimately, c-di-GMP influences the ability of a bacterium to alter its transcriptional program, physiology and behavior upon surface contact. This review discusses how bacteria are able to sense a surface via flagella and type IV pili, and the role of c-di-GMP in regulating the response to surfaces, with emphasis on studies of Gram-positive bacteria.
引用
收藏
页码:753 / 773
页数:21
相关论文
共 50 条
  • [21] Motility and adhesion through type IV pili in Gram-positive bacteria
    Piepenbrink, Kurt H.
    Sundberg, Eric J.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 1659 - 1666
  • [22] The Role of Functional Amyloids in Multicellular Growth and Development of Gram-Positive Bacteria
    Dragos, Anna
    Kovacs, Akos T.
    Claessen, Dennis
    BIOMOLECULES, 2017, 7 (03):
  • [23] Atomic structures of a bacteriocin targeting Gram-positive bacteria
    Cai, Xiaoying
    He, Yao
    Yu, Iris
    Imani, Anthony
    Scholl, Dean
    Miller, Jeff F.
    Zhou, Z. Hong
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [24] Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria
    Assoni, Lucas
    Milani, Barbara
    Carvalho, Marianna Ribeiro
    Nepomuceno, Lucas Natanael
    Waz, Natalha Tedeschi
    Guerra, Maria Eduarda Souza
    Converso, Thiago Rojas
    Darrieux, Michelle
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [25] Extracellular vesicles: An emerging platform in gram-positive bacteria
    Bose, Swagata
    Aggarwal, Shifu
    Singh, Durg Vijai
    Acharya, Narottam
    MICROBIAL CELL, 2020, 7 (12): : 312 - 322
  • [26] Evaluation of Antibiotic Resistance Mechanisms in Gram-Positive Bacteria
    Rajput, Pratiksing
    Nahar, Kazi S.
    Rahman, Khondaker Miraz
    ANTIBIOTICS-BASEL, 2024, 13 (12):
  • [27] Uptake of Ozenoxacin and Other Quinolones in Gram-Positive Bacteria
    Lopez, Yuly
    Munoz, Laura
    Gargallo-Viola, Domingo
    Canton, Rafael
    Vila, Jordi
    Zsolt, Ilonka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [28] Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria
    Nawrocki, Kathryn L.
    Crispell, Emily K.
    McBride, Shonna M.
    ANTIBIOTICS-BASEL, 2014, 3 (04): : 461 - 492
  • [29] Cyclodepsipeptides produced by actinomycetes inhibit cyclic-peptide-mediated quorum sensing in Gram-positive bacteria
    Desouky, Said E.
    Shojima, Akane
    Singh, Ravindra Pal
    Matsufuji, Takahisa
    Igarashi, Yasuhiro
    Suzuki, Takashi
    Yamagaki, Tohru
    Okubo, Ken-ichi
    Ohtani, Kaori
    Sonomoto, Kenji
    Nakayama, Jiro
    FEMS MICROBIOLOGY LETTERS, 2015, 362 (14)
  • [30] Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria
    Kastoris, Antonia C.
    Rafailidis, Petros I.
    Vouloumanou, Evridiki K.
    Gkegkes, Ioannis D.
    Falagas, Matthew E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (04) : 359 - 368